| 000 | 00837nam a2200253Ia 4500 | ||
|---|---|---|---|
| 001 | 288006 | ||
| 003 | OCoLC | ||
| 005 | 20160527201648.0 | ||
| 008 | 080727s2008 xx 000 0 eng d | ||
| 020 | _a0735576637 | ||
| 020 | _a9780735576636 | ||
| 035 | _a(OCoLC)236185777 | ||
| 040 | _aPUCPR | ||
| 049 | _acicg | ||
| 050 | 0 | 0 |
_aKF 3894 .G45 _bB443 2008 |
| 100 | 1 |
_aBeers, Donald O. _2Local _959269 |
|
| 245 | 1 | 0 |
_aGeneric and innovator drugs _ba guide to FDA approval requirements. |
| 250 | _a7th ed. | ||
| 260 |
_aFrederick _bAspen Publ. Inc. _c2008. |
||
| 300 |
_ap. (loose-leaf) _c26 cm. |
||
| 650 | 0 |
_aDrugs _xGeneric substitution _xLaw and legislation _zUnited States. _2Local _988821 |
|
| 650 | 0 |
_aPatent extensions _zUnited States. _2Local _9148191 |
|
| 650 | 0 |
_aDrugs _zUnited States _xGeneric substitution _xPatents. _2Local _988821 |
|
| 999 |
_c208259 _d208259 |
||